title: At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.
authors.affiliation: The First Clinical College, Nanjing Traditional Chinese Medicine University, Nanjing, China.
authors.forename: Defeng
authors.initials: D
authors.lastname: Pan
authors.affiliation: The First Clinical College, Nanjing Traditional Chinese Medicine University, Nanjing, China;; Institute of cardiovascular diseases, Xuzhou Medical University, Xuzhou, China.
authors.forename: Dongye
authors.initials: D
authors.lastname: Li